Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05308654 |
|---|---|
| Brief Title: | A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets |
| First Submitted : | March 25, 2022 |
| First Submitted that Met QC Criteria : | March 25, 2022 |
| First Posted : | April 4, 2022 |
| Last Update Submitted that Met QC Criteria : | January 24, 2024 |
| Last Update Posted : | January 25, 2024 |